Prognostic Factors Related to Clinical Response in Patients With Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-0187
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Metastatic Melanoma: Prognostic Factors and Survival in Patients With Brain Metastases

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2017English

Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

Uncommon BRAF Mutations Associated With Durable Response to Immunotherapy in Patients With Metastatic Melanoma

Case Reports in Oncological Medicine
Oncology
2017English

CTLA4 Blockade Increases Th17 Cells in Patients With Metastatic Melanoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2009English

Influence of Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA4) Common Polymorphisms on Outcome in Treatment of Melanoma Patients With CTLA-4 Blockade

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2008English

Corrigendum: Association of CTLA-4 Gene Variants With Response to Therapy and Long-Term Survival in Metastatic Melanoma Patients Treated With Ipilimumab: An Italian Melanoma Intergroup Study

Frontiers in Immunology
AllergyImmunology
2018English

Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib-Treated Patients With BRAFV600-mutated Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Prognostic Factors for Patients Treated With Abiraterone

Future Science OA
MedicineBiotechnology
2019English

Prognostic Factors in Metastatic Pancreatic Cancer: Older Patients Are Associated With Reduced Overall Survival

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy